Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the path: Advice to physician-scientists on choosing a clinical specialty.

eLife·2026
Same author

Selenium, senescent neutrophils and the expanding biology of selenoprotein P in cancer.

Gut·2026
Same author

Stabilizing and strengthening the US physician-scientist faculty workforce in academic medicine: a proposed institutional framework.

JCI insight·2026
Same author

Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cells.

Blood advances·2026
Same author

<i>Trsp</i> is required by regulatory T cells to prevent lethal autoimmunity in mice.

bioRxiv : the preprint server for biology·2025
Same author

An insider's guide to understanding and obtaining an NIH K career development award.

JCI insight·2025

Related Experiment Video

Updated: May 4, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

8.4K

High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis.

Lori A Coburn1, Sara N Horst1, Rupesh Chaturvedi2

  • 1Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America ; Veterans Affairs Tennessee Valley Healthcare System, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

Plos One
|December 25, 2013
PubMed
Summary
This summary is machine-generated.

Eotaxin-1 is elevated in ulcerative colitis (UC) patients and may be a therapeutic target. Luminex assays can help identify patients for targeted anti-cytokine therapies in inflammatory bowel disease (IBD).

More Related Videos

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

7.5K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.0K

Related Experiment Videos

Last Updated: May 4, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

8.4K
Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

7.5K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.0K

Area of Science:

  • Gastroenterology
  • Immunology
  • Biomarker Discovery

Background:

  • Inflammatory bowel disease (IBD) requires new therapeutic targets and methods for therapy optimization.
  • Multi-analyte protein assays, such as Luminex technology, offer high-throughput analysis of cytokines and chemokines.

Purpose of the Study:

  • To assess the utility of Luminex-based multiplex assays for cytokine/chemokine profiling in ulcerative colitis (UC).
  • To identify potential biomarkers and therapeutic targets in UC pathogenesis.

Main Methods:

  • Prospective study of serum and colon biopsies from 137 UC patients and 38 controls.
  • Luminex-based multiplex testing of 42 analytes in serum and tissue.
  • Correlation of cytokine/chemokine levels with disease activity (Mayo Disease Activity Index) and histology.
  • Validation of eotaxin-1 levels using real-time PCR and murine colitis models.

Main Results:

  • Eotaxin-1 and G-CSF were elevated in serum of active UC patients compared to controls.
  • Thirteen cytokines/chemokines were increased in UC tissues; eotaxin-1 was elevated across all disease activity levels in both serum and tissue.
  • Tissue eotaxin-1 correlated with disease activity index and eosinophil counts.
  • Elevated tissue eotaxin-1 was observed in multiple murine colitis models, but not in H. pylori infection.

Conclusions:

  • Eotaxin-1 is implicated as an etiological factor and potential therapeutic target in UC.
  • Luminex-based assays are valuable for assessing IBD pathogenesis.
  • These assays can aid in selecting patients for anti-cytokine/chemokine therapies.